Ads
related to: breast cancer cell receptors
Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 13 hours agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Luton man treated for breast cancer given 'wonder drug'
BBC News· 13 hours agoA man who was given "a wonder drug" to target his stage four cancer said it was "like an oasis in...
Edgewood Oncology treats first two subjects in breast cancer trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe multicentre, open-label, nonrandomised, multiple dose study is designed...resistance to these...
Mirat Shah, MD, on Elacestrant's FDA Approval for Breast Cancer With ESR1 Mutations
MedPage Today· 6 days agoFDA scientists published a detailed rationale for the approval of elacestrant (Orserdu), the first...
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...
Nature· 6 days agoCancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical ...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 4 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical...
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
Medscape· 7 days agoADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.
Nuclear receptors — studying genes to understand hormones - Nature Reviews Genetics
Nature· 5 days agoLigand-bound receptors undergo conformational changes to facilitate binding both to DNA and to co-factors that facilitate interactions with chromatin and core transcriptional ...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 4 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical ..
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 3 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...